Bfarm warns: Kratom dangerous for health and quality of life!

Bfarm warns: Kratom dangerous for health and quality of life!

Berlin, Deutschland - The Federal Institute for Medicines and Medical Devices (BfArM) has again warned of medical purposes before using Kratom. The herbal preparation, which is obtained from the leaves of the Kratombaes native to Southeast Asia, is not approved in Germany as a medicine. This warning comes, while the interest in Kratom as a supposed remedy for various diseases such as pain, inflammation, coughing, fear and depression grows. However, experts fear that the security and effectiveness of Kratom have so far not been adequately checked, which significantly increases the risks of health. rbbb24 reports that medicinal products are only approved if their effectiveness and quality are proven by an official approval process. This does not apply to Kratom.

An increasing number of studies shows possible harmful neurological effects associated with the use of Kratom. In addition to dependency, this also includes withdrawal syndromes. In addition, the substance can cause considerable damage to the liver and kidneys. Exact causes of death that are related to Kratom are still the subject of scientific studies. The BfArM remains in close exchange with the responsible state authorities to monitor drug traffic and possibly prepare necessary measures for patient safety.

risks and side effects

Kratom is stimulating in low doses and dampening in higher doses and psychoactive, similar to opioids. Typical side effects are flu -like symptoms, chills, sweats, nausea and vomiting. [The Consumer Center] (https://www. consumerzentrale.de/wissen/fezeensmittel/kahnsengaenzmittel/kratom-erlewalliche- risk-27156) warned of the consumption of Kratom in December and referred to the associated dangers. An uncontrolled distribution of Kratom products can also bring risks due to contamination such as toxic heavy metals or salmonella.

The US FDA evaluated comprehensive research data on Kratom in 2024 and warned of the use of Kratom and its connections. There are also efforts in the European Union to clarify the legal framework for Kratom. Kratom could fall under the term "new food", since regular consumption has not been proven since May 1997. Investigations in the European Fast Warning System Rasff led to warning reports on Kratom products, including concerns about their ingredients and security standards.

regulation and future

In Germany, the legal classification of Kratom remains unclear. While some state authorities are already implementing measures for patient safety, the classification is still open as a drug subject to approval. Critics argue that the application from Kratom as a therapeutic means should lead to a faster regulatory answer in order to minimize potential health risks for consumers. The BfArM has set up a joint expert commission to examine these questions and to discuss the classification of products containing Kratom.

The developments related to Kratom raise important questions about the benefits and dangers of this substance. While countries like the United States have already introduced regulations to control the Kratom consumption, Germany is still at an early stage of regulation. In view of the health risks available, it is crucial that consumers remain informed and are aware of the possible dangers.